Limiting access to letrozole--is it justified?

Togas Tulandi; Alan H DeCherney

doi:10.1016/j.fertnstert.2007.01.115

Limiting access to letrozole--is it justified?

Fertil Steril. 2007 Oct;88(4):779-80. doi: 10.1016/j.fertnstert.2007.01.115. Epub 2007 Apr 26.

Authors

Togas Tulandi¹, Alan H DeCherney

Affiliation

¹ Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada. togas.tulandi@mcgill.ca

PMID: 17462638
DOI: 10.1016/j.fertnstert.2007.01.115

Abstract

Letrozole is an effective drug for ovulation induction and superovulation. Limiting its access is a disservice to our infertile patients and to the advancement in ovulation-related research.

Publication types

Editorial

MeSH terms

Aromatase Inhibitors / adverse effects
Aromatase Inhibitors / supply & distribution*
Female
Heart Defects, Congenital / chemically induced*
Humans
Infant, Newborn
Infertility, Female / drug therapy*
Letrozole
Nitriles / adverse effects*
Nitriles / therapeutic use
Ovulation Induction / methods
Pregnancy
Triazoles / adverse effects*
Triazoles / therapeutic use

Substances

Aromatase Inhibitors
Nitriles
Triazoles
Letrozole